PEAK6 Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-8,932
| Closed | -$1.85M | – | 1140 |
|
2024
Q2 | $1.85M | Buy |
8,932
+5,786
| +184% | +$1.2M | ﹤0.01% | 205 |
|
2024
Q1 | $852K | Buy |
+3,146
| New | +$852K | ﹤0.01% | 330 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 1308 |
|
2023
Q3 | – | Sell |
-1,673
| Closed | -$352K | – | 1263 |
|
2023
Q2 | $352K | Buy |
1,673
+600
| +56% | +$126K | ﹤0.01% | 447 |
|
2023
Q1 | $217K | Buy |
+1,073
| New | +$217K | ﹤0.01% | 659 |
|
2022
Q4 | – | Sell |
-3,311
| Closed | -$652K | – | 1481 |
|
2022
Q3 | $652K | Sell |
3,311
-458
| -12% | -$90.2K | ﹤0.01% | 631 |
|
2022
Q2 | $801K | Sell |
3,769
-639
| -14% | -$136K | ﹤0.01% | 811 |
|
2022
Q1 | $1.25M | Sell |
4,408
-12,415
| -74% | -$3.53M | ﹤0.01% | 471 |
|
2021
Q4 | $6.34M | Sell |
16,823
-24,850
| -60% | -$9.36M | 0.01% | 128 |
|
2021
Q3 | $17.2M | Buy |
41,673
+41,669
| +1,041,725% | +$17.2M | 0.04% | 59 |
|
2021
Q2 | $1K | Sell |
4
-12,794
| -100% | -$3.2M | ﹤0.01% | 1670 |
|
2021
Q1 | $3.71M | Buy |
12,798
+6,136
| +92% | +$1.78M | 0.01% | 256 |
|
2020
Q4 | $1.67M | Buy |
+6,662
| New | +$1.67M | ﹤0.01% | 497 |
|
2020
Q3 | – | Sell |
-1,043
| Closed | -$182K | – | 1368 |
|
2020
Q2 | $182K | Sell |
1,043
-13,372
| -93% | -$2.33M | ﹤0.01% | 836 |
|
2020
Q1 | $1.82M | Buy |
14,415
+1,473
| +11% | +$186K | 0.01% | 230 |
|
2019
Q4 | $1.98M | Buy |
12,942
+11,753
| +988% | +$1.8M | 0.01% | 263 |
|
2019
Q3 | $157K | Sell |
1,189
-8,829
| -88% | -$1.17M | ﹤0.01% | 797 |
|
2019
Q2 | $1.42M | Sell |
10,018
-1,606
| -14% | -$228K | 0.01% | 359 |
|
2019
Q1 | $1.69M | Buy |
11,624
+10,319
| +791% | +$1.5M | 0.01% | 289 |
|
2018
Q4 | $148K | Buy |
+1,305
| New | +$148K | ﹤0.01% | 882 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1222 |
|